文献速递妇科产科母胎医学

针对乳腺癌和卵巢癌高遗传风险女性的以患者为中心的激素替代治疗教育的开发与测试

Development and testing of patient-centered education about hormone replacement therapy for women at high genetic risk of breast and ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2023-12-26

本研究纳入25名19-49岁、无癌症史且未行降低风险输卵管卵巢切除术的绝经前BRCA突变携带者,通过结构化访谈评估关于HRT利弊的教育材料。教育后决策冲突量表(DCS)总分从54.6显著降至22.8(p<0.001),各亚项评分也显著下降;参与者将心血管疾病列为最需考虑的结果,乳房切除史影响对乳腺癌重要性的排序。

要点

  • 教育后BRCA突变携带者关于HRT的决策冲突显著降低(DCS 54.6降至22.8,p<0.001)。
  • 参与者将心血管疾病视为最重要的考虑结果,其次为乳腺癌、骨质疏松、血栓、性功能下降和潮热。
  • 有乳房切除史者(N=10)将乳腺癌列为最重要结果的比例为25%,无乳房切除史者(N=15)为80%。

核心结论

  • 教育后BRCA突变携带者关于是否使用HRT的决策冲突显著减少。
  • 本试点研究成功生成了一套教育辅助工具原型,供进一步测试。

研究设计与样本

  • 研究纳入19-49岁、无癌症史且未行降低风险输卵管卵巢切除术的绝经前BRCA突变携带者,进行结构化访谈。
  • 参与者审阅关于HRT风险与获益的教育材料,材料包含文献来源的HRT与常见健康结局关联的数据。
  • 参与者在教育前后完成16项决策冲突量表(DCS),并对六项结局进行评分和排序,提供反馈以迭代修订教育内容。
  • 共25名参与者完成访谈。

主要发现

  • 教育后DCS总分从54.6降至22.8(p<0.001)。
  • 不确定性亚项从71.7降至37.3,知情亚项从71.7降至15.3,价值观清晰亚项从53.7降至17.0,有效决策亚项从44.2降至25.5,支持亚项从35.0降至17.7,均显著下降。
  • 参与者将心血管疾病列为最重要考虑结果,其次为乳腺癌、骨质疏松、血栓、性功能下降和潮热。
  • 有乳房切除史者(N=10)将乳腺癌列为最重要结果的比例为25%,无乳房切除史者(N=15)为80%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In this study, we aimed to develop education to assist BRCA mutation carriers in making informed decisions about HRT in the context of risk-reducing surgery, while simultaneously clarifying their treatment-specific values and reducing decisional conflict. METHODS: We enrolled premenopausal BRCA mutation carriers ages 19-49 without prior cancer or risk-reducing salpingo-oophorectomy to structured interviews in which they reviewed education about the risks and benefits of HRT. Materials included literature-derived data demonstrating associations between HRT and commonly considered health outcomes (breast cancer, vasomotor symptoms, sexual functioning, cardiovascular disease, osteoporosis, and blood clots). Participants completed the 16-item Decisional Conflict Scale (DCS) before and after education, communicated their preferences by rating and ranking the six outcomes, and provided feedback to inform iterative revisions of the educational content. RESULTS: 25 participants completed interviews. DCS scores decreased significantly from 54.6 to 22.8 following education (p < 0.001); sub-scores for uncertainty (71.7 to 37.3), informed (71.7 to 15.3), values clarity (53.7 to 17.0), effective decision (44.2 to 25.5), and support (35.0 to 17.7) also decreased significantly. Participants ranked cardiovascular disease as the most important outcome to consider, followed by breast cancer, osteoporosis, blood clots, decline in sexual function, and hot flashes. Participants with prior mastectomy (N = 10) ranked breast cancer as the most important outcome 25% of the time, compared to 80% in participants without mastectomy (N = 15). CONCLUSION: Following education, BRCA mutation carriers had significantly less decisional conflict regarding the choice to use HRT. This pilot study was successful in generating a prototype educational aid for further testing.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Penvose KN, Reed SD, Sepulveda JMG, et al. Development and testing of patient-centered education about hormone replacement therapy for women at high genetic risk of breast and ovarian cancer. Gynecol Oncol. 2023. PMID: 38150837. doi:10.1016/j.ygyno.2023.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。